ジーエヌアイグループの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/02/22 | 1,257 | 1,265 | 1,110 | 1,118 | -180 | -13.9% | 2,652,900 |
| 2022/02/21 | 1,205 | 1,310 | 1,204 | 1,298 | +94 | +7.8% | 2,141,800 |
| 2022/02/18 | 1,215 | 1,243 | 1,142 | 1,204 | -41 | -3.3% | 1,591,700 |
| 2022/02/17 | 1,233 | 1,269 | 1,212 | 1,245 | -10 | -0.8% | 903,800 |
| 2022/02/16 | 1,250 | 1,291 | 1,225 | 1,255 | +44 | +3.6% | 1,322,000 |
| 2022/02/15 | 1,172 | 1,355 | 1,140 | 1,211 | +69 | +6% | 3,873,300 |
| 2022/02/14 | 1,130 | 1,149 | 1,111 | 1,142 | -28 | -2.4% | 585,900 |
| 2022/02/10 | 1,161 | 1,192 | 1,161 | 1,170 | +25 | +2.2% | 631,900 |
| 2022/02/09 | 1,123 | 1,153 | 1,074 | 1,145 | +36 | +3.2% | 814,300 |
| 2022/02/08 | 1,147 | 1,148 | 1,106 | 1,109 | -22 | -1.9% | 431,500 |
| 2022/02/07 | 1,163 | 1,189 | 1,129 | 1,131 | -21 | -1.8% | 580,300 |
| 2022/02/04 | 1,153 | 1,183 | 1,125 | 1,152 | -12 | -1% | 630,100 |
| 2022/02/03 | 1,141 | 1,194 | 1,126 | 1,164 | +5 | +0.4% | 953,200 |
| 2022/02/02 | 1,095 | 1,176 | 1,095 | 1,159 | +69 | +6.3% | 1,187,200 |
| 2022/02/01 | 1,042 | 1,107 | 1,031 | 1,090 | +49 | +4.7% | 1,490,500 |
| 2022/01/31 | 935 | 1,112 | 918 | 1,041 | -144 | -12.2% | 4,188,000 |
| 2022/01/28 | 1,200 | 1,217 | 1,150 | 1,185 | -8 | -0.7% | 1,050,400 |
| 2022/01/27 | 1,247 | 1,260 | 1,189 | 1,193 | -67 | -5.3% | 1,120,600 |
| 2022/01/26 | 1,258 | 1,274 | 1,220 | 1,260 | +14 | +1.1% | 727,400 |
| 2022/01/25 | 1,348 | 1,364 | 1,234 | 1,246 | -102 | -7.6% | 1,548,300 |
| 2022/01/24 | 1,366 | 1,369 | 1,326 | 1,348 | -48 | -3.4% | 762,100 |
| 2022/01/21 | 1,457 | 1,462 | 1,378 | 1,396 | -58 | -4% | 697,900 |
| 2022/01/20 | 1,401 | 1,455 | 1,398 | 1,454 | +44 | +3.1% | 538,500 |
| 2022/01/19 | 1,379 | 1,422 | 1,378 | 1,410 | +6 | +0.4% | 474,100 |
| 2022/01/18 | 1,411 | 1,446 | 1,394 | 1,404 | +25 | +1.8% | 614,500 |
| 2022/01/17 | 1,400 | 1,414 | 1,376 | 1,379 | -23 | -1.6% | 292,900 |
| 2022/01/14 | 1,381 | 1,405 | 1,347 | 1,402 | +7 | +0.5% | 604,100 |
| 2022/01/13 | 1,405 | 1,428 | 1,395 | 1,395 | -25 | -1.8% | 391,000 |
| 2022/01/12 | 1,425 | 1,453 | 1,405 | 1,420 | -28 | -1.9% | 560,500 |
| 2022/01/11 | 1,380 | 1,452 | 1,365 | 1,448 | +73 | +5.3% | 628,800 |
| 2022/01/07 | 1,387 | 1,388 | 1,339 | 1,375 | +4 | +0.3% | 514,500 |
| 2022/01/06 | 1,400 | 1,423 | 1,359 | 1,371 | -59 | -4.1% | 629,800 |
| 2022/01/05 | 1,450 | 1,451 | 1,416 | 1,430 | -42 | -2.9% | 489,400 |
| 2022/01/04 | 1,500 | 1,501 | 1,443 | 1,472 | -9 | -0.6% | 422,600 |
| 2021/12/30 | 1,454 | 1,494 | 1,446 | 1,481 | +8 | +0.5% | 388,300 |
| 2021/12/29 | 1,385 | 1,488 | 1,385 | 1,473 | +91 | +6.6% | 906,200 |
| 2021/12/28 | 1,392 | 1,403 | 1,360 | 1,382 | -3 | -0.2% | 875,500 |
| 2021/12/27 | 1,418 | 1,418 | 1,372 | 1,385 | -39 | -2.7% | 570,600 |
| 2021/12/24 | 1,439 | 1,445 | 1,410 | 1,424 | +7 | +0.5% | 383,000 |
| 2021/12/23 | 1,392 | 1,424 | 1,387 | 1,417 | +16 | +1.1% | 441,700 |
| 2021/12/22 | 1,367 | 1,407 | 1,349 | 1,401 | +53 | +3.9% | 677,400 |
| 2021/12/21 | 1,330 | 1,359 | 1,307 | 1,348 | +42 | +3.2% | 531,000 |
| 2021/12/20 | 1,310 | 1,338 | 1,303 | 1,306 | -11 | -0.8% | 494,100 |
| 2021/12/17 | 1,331 | 1,351 | 1,307 | 1,317 | -24 | -1.8% | 587,800 |
| 2021/12/16 | 1,376 | 1,383 | 1,339 | 1,341 | -8 | -0.6% | 372,100 |
| 2021/12/15 | 1,335 | 1,359 | 1,331 | 1,349 | +4 | +0.3% | 306,500 |
| 2021/12/14 | 1,376 | 1,387 | 1,337 | 1,345 | -36 | -2.6% | 480,900 |
| 2021/12/13 | 1,428 | 1,429 | 1,376 | 1,381 | -25 | -1.8% | 329,900 |
| 2021/12/10 | 1,431 | 1,442 | 1,403 | 1,406 | -37 | -2.6% | 308,400 |
| 2021/12/09 | 1,460 | 1,484 | 1,440 | 1,443 | -12 | -0.8% | 382,000 |
701～
750
件表示中 / 3611件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ジーエヌアイ | 361,000円 | +52.1% | +23.3% | - | - | - |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 科研薬 | 450,000円 | +22.8% | +113.0% | - | - | - |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| キッセイ薬 | 417,000円 | +14.5% | -2.3% | - | - | - |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 東和薬品 | 333,000円 | +15.0% | -7.3% | - | - | - |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| 鳥居薬 | 469,500円 | +12.0% | +28.1% | - | - | - |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
市場注目の銘柄
チャート関連のコラム
